Literature DB >> 11304737

Comparisons of two-part models with competitors.

P A Lachenbruch1.   

Abstract

Two-part models arise when there is a clump of 0 observations in a distribution of continuous non-negative responses. Several methods for comparing two such distributions are available. These include the straightforward application of the z-test (or t-test), the Wilcoxon-Mann-Whitney rank sum test, the Kolmogorov-Smirnov test, and three tests that use a 2 degree of freedom chi(2) test based on the sum of the test for equality of proportions and a conditional chi(2) test for the continuous responses. This conditional test may be the z-test, the rank sum test, or the chi(2) corresponding to the Kolmogorov-Smirnov test. This study compares the size and power of several of these methods. All tests have the appropriate distribution under the null hypothesis if the distribution of the continuous part has finite moments. If it does not, the z-test has no power to detect any alternatives. It is found that the 2 d.f. tests are superior to the others when the larger proportion of 0 values corresponds to the population with the larger mean. If the reverse holds, the difference in the proportion of zeros reinforces the difference in means and some single-part models (the rank sum or Kolmogorov-Smirnov) do best. In those cases, the two-part models are not far behind, although statistically significantly poorer with respect to power. Published in 2001 by John Wiley & Sons, Ltd.

Mesh:

Year:  2001        PMID: 11304737     DOI: 10.1002/sim.790

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  32 in total

1.  Cost of Hospital Admissions in Medicare Patients With Atrial Fibrillation Taking Warfarin, Dabigatran, or Rivaroxaban.

Authors:  Mary S Vaughan Sarrazin; Michael Jones; Alexander Mazur; Peter Cram; Padmaja Ayyagari; Elizabeth Chrischilles
Journal:  J Am Coll Cardiol       Date:  2017-01-24       Impact factor: 24.094

2.  Null but not void: considerations for hypothesis testing.

Authors:  Pamela A Shaw; Michael A Proschan
Journal:  Stat Med       Date:  2012-07-16       Impact factor: 2.373

3.  Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.

Authors:  Stephen R Walsh; Zoe Moodie; Andrew J Fiore-Gartland; Cecilia Morgan; Marissa B Wilck; Scott M Hammer; Susan P Buchbinder; Spyros A Kalams; Paul A Goepfert; Mark J Mulligan; Michael C Keefer; Lindsey R Baden; Edith M Swann; Shannon Grant; Hasan Ahmed; Fusheng Li; Tomer Hertz; Steven G Self; David Friedrich; Nicole Frahm; Hua-Xin Liao; David C Montefiori; Georgia D Tomaras; M Juliana McElrath; John Hural; Barney S Graham; Xia Jin
Journal:  J Infect Dis       Date:  2015-10-15       Impact factor: 5.226

4.  Multivariate two-part statistics for analysis of correlated mass spectrometry data from multiple biological specimens.

Authors:  Sandra L Taylor; L Renee Ruhaak; Robert H Weiss; Karen Kelly; Kyoungmi Kim
Journal:  Bioinformatics       Date:  2016-09-04       Impact factor: 6.937

5.  Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial.

Authors:  Esper G Kallas; Nicole A Grunenberg; Chenchen Yu; Bryce Manso; Giuseppe Pantaleo; Martin Casapia; Lindsey R Baden; Javier Valencia; Magdalena Sobieszczyk; Hong Van Tieu; Mary Allen; John Hural; Barney S Graham; James Kublin; Peter B Gilbert; Lawrence Corey; Paul A Goepfert; M Juliana McElrath; R Paul Johnson; Yunda Huang; Nicole Frahm
Journal:  Sci Transl Med       Date:  2019-11-20       Impact factor: 17.956

6.  Models to Assess the Association of a Semiquantitative Exposure With Outcomes.

Authors:  John M Lachin; Ionut Bebu; Barbara Braffett
Journal:  Am J Epidemiol       Date:  2020-12-01       Impact factor: 4.897

7.  An Evaluation of Statistical Methods for Analyzing Follow-Up Gaussian Laboratory Data with a Lower Quantification Limit.

Authors:  John M Karon; Ryan E Wiegand; Janneke H van de Wijgert; Peter H Kilmarx
Journal:  J Biopharm Stat       Date:  2015       Impact factor: 1.051

8.  High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network.

Authors:  Sarah L Logan; Joyce S Nicholas; Laura A Carpenter; Lydia B King; Elizabeth Garrett-Mayer; Jane M Charles
Journal:  Ann Epidemiol       Date:  2012-01       Impact factor: 3.797

9.  Variance components genetic association test for zero-inflated count outcomes.

Authors:  Matthew O Goodman; Lori Chibnik; Tianxi Cai
Journal:  Genet Epidemiol       Date:  2018-10-24       Impact factor: 2.135

10.  Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.

Authors:  Adam R Hersperger; Florencia Pereyra; Martha Nason; Korey Demers; Prameet Sheth; Lucy Y Shin; Colin M Kovacs; Benigno Rodriguez; Scott F Sieg; Leia Teixeira-Johnson; Debbie Gudonis; Paul A Goepfert; Michael M Lederman; Ian Frank; George Makedonas; Rupert Kaul; Bruce D Walker; Michael R Betts
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.